Published Paper Details:

Background: COVID-19, caused by the SARS-CoV-2 virus, is a pandemic that started in Wuhan, China in 2019 and quickly spread globally. The WHO declared it a pandemic in March 2020. In India, Covishield and Covaxin have been granted emergency use authorization and the administration of COVID-19 vaccines began in January 2021. Immunization against Coronavirus has turned into the promising system in controlling ascent in Coronavirus cases. Methodology: A cross-sectional survey study was conducted to assess COVID-19 vaccine side effects in major cities of Gujarat, India. The study used a descriptive research design and collected data from 420 participants over 18 years of age residing in Gujarat through an online questionnaire. Result: Covishield vaccine has higher side effects (fever, pain, body pain, and headache) than Covaxin (fever, body pain). Side effects were less in 2nd dose and precaution doses compared to 1st dose. 7.2% people have experienced acute illness and some medical conditions. The prevalence of infection after vaccination was 20.34% among the participants. Conclusion: Side effects were seen due to the COVID-19 vaccination. Some experienced acute illness and medical conditions. Few people noticed infection after COVID-19 vaccination